SCHEMBL14075409

SCHEMBL14075409

O=C(O)c1ccc(S(=O)(=O)Nc2cc(C(=O)O)ccc2Oc2cc(C(=O)O)cc(C(=O)O)c2)cc1

nearest known ligand 0.61

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
CCR2 P41597 4/20 0.61
CCR1 P32246 1/20 0.61
CCR5 P51681 1/20 0.61
CYP2C9 P11712 1/20 0.53
PTGDR2 Q9Y5Y4 8/20 0.51
ALDH1A1 P00352 2/20 0.49
KDM4E B2RXH2 1/20 0.49
LMNA P02545 1/20 0.49
PTPN1 P18031 1/20 0.49
GFER P55789 1/20 0.49
WDR5 P61964 1/20 0.48
CA12 O43570 1/20 0.46
CA1 P00915 1/20 0.46
CA2 P00918 1/20 0.46
CA9 Q16790 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14075413 0.92 PTGDR2 (0.58) CCR2CCR1CCR5CYP2C9PTGDR2
SCHEMBL14075412 0.92 CCR2 (0.54) CCR2CCR1CCR5CYP2C9PTGDR2
SCHEMBL14075411 0.88 ALDH1A1 (0.56) CYP2C9ALDH1A1KDM4ELMNA
SCHEMBL3049477 0.82 CCR2 (0.62) CCR2CCR1CCR5ALDH1A1KDM4E
SCHEMBL14311391 0.81 CYP2C9 (0.60) CCR2CCR1CCR5CYP2C9PTGDR2
SCHEMBL3050565 0.81 CCR2 (0.64) CCR2CCR1CCR5PTGDR2ALDH1A1
SCHEMBL2897956 0.80 CCR1 (0.60) CCR2CCR1CCR5CYP2C9PTGDR2
SCHEMBL3039982 0.78 CCR2 (0.58) CCR2CCR1CCR5CYP2C9KDM4E
SCHEMBL4505489 0.78 PTGDR2 (0.68) CCR2CCR1CCR5PTGDR2ALDH1A1
SCHEMBL13816298 0.76 PTGDR2 (0.59) CCR2CCR1CCR5CYP2C9PTGDR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7429677-B2 Small molecule entry inhibitors TIBOTEC PHARMACEUTICALS LTD. (IE) 2008-09-30 US disclosed
US-7429677-B2 Small molecule entry inhibitors TIBOTEC PHARMACEUTICALS LTD. (IE) 2008-09-30 US disclosed